Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.21 -0.02 (-0.91%)
As of: Sep 29, 2026 · 3:40 PM EDT

Xtl Biopharmaceuticals (XTLB) Net Margin (2011 - 2024)

Updated

Xtl Biopharmaceuticals' Net Margin was -88.24% in the quarter ended Dec 31, 2024.

Analysis

Xtl Biopharmaceuticals (XTLB) Net Margin (2011 - 2024) Analysis & Trends

For the year ended Dec 31, 2024, Net Margin at Xtl Biopharmaceuticals came in at -227.72%.

  • The figure for the quarter ended Dec 31, 2024 marks the highest quarterly Net Margin since the quarter ended Mar 31, 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Xtl Biopharmaceuticals 2.11 Bn 2.11 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -88.24%
Dec 31, 2020 -8,966.67%
Mar 31, 2020 2,471.43%
Sep 30, 2014 -197.91%
Jun 30, 2014 -186.84%
Mar 31, 2014 -129.64%
Dec 31, 2013 -161.74%
Sep 30, 2013 77.80%
Jun 30, 2013 -195.90%
Mar 31, 2013 -129.57%
Dec 31, 2012 -49.75%
Sep 30, 2012 -14.58%
Jun 30, 2012 -148.12%
Mar 31, 2012 32.87%
Dec 31, 2011 -15.67%
Sep 30, 2011 -89.60%
Jun 30, 2011 -51.99%
API Access

Xtl Biopharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=XTLB&period=max&api_key=YOUR_API_KEY